However, creatine biosynthesis and metabolism are highly dependent on many factors such as diet, hormones, and age [11,12]
Im besonderen Bedarfsfall kommt N-Acetyl-Cystein (NAC) zum Zug
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by thrombotic, non-thrombotic, and obstetric manifestations in individuals with persistent antiphospholipid antibodies (aPL)
10.1016/j.pharmthera.2018.03.004 30 DaiP.WangJ.LinL.ZhangY.WangZ
Study-related adverse events Adverse reactions reported in 5% of patients and occurring more frequently with Victoza compared with placebo included nausea (21.4% vs 4.4%), vomiting (12.1% vs 2.2%), diarrhea (7.1% vs 2.9%), constipation (5.7% vs 1.5%), increased lipase (15.0% vs 8.8%), GFR decreased (6.4% vs 5.1%), and headache (5.0% vs 2.9%)
Several factors explain the lack of approval: insufficient clinical trials (no completed Phase 3 trials for most indications), safety concerns (FDA has identified specific adverse events), commercial considerations (patent status affects development investment), regulatory pathway (approval requires specific, rigorous documentation), and competition (Tesamorelin already approved for related indication)
